What is the Rapid Plasma Reagin (RPR) Test for Syphilis?
The RPR test is a nontreponemal antibody blood test that detects antibodies produced in response to cellular damage from syphilis infection, serving as both a screening tool and a quantitative marker for disease activity and treatment response.
Test Characteristics and Purpose
The RPR is one of several nontreponemal tests (along with VDRL, USR, and RST) that detect reagin antibodies—not antibodies directly against Treponema pallidum, but rather antibodies against cardiolipin-lecithin-cholesterol antigens released from damaged cells during infection 1. This makes it:
- A screening test for active syphilis infection
- A quantitative marker reported in titers (e.g., 1:4,1:16,1:64) that correlates with disease activity
- A monitoring tool to assess treatment response and detect reinfection
The test was developed in the 1950s-60s as a rapid alternative to VDRL that could use plasma instead of serum, making specimen collection easier 2.
Performance Characteristics by Disease Stage
Based on high-quality studies using darkfield microscopy as the gold standard 1:
Primary Syphilis
- Sensitivity: 62-93% (varies across studies, with most showing 63-77%)
- The test may be negative early in primary infection before antibody development
- Sensitivity increases as the chancre matures
Secondary Syphilis
- Sensitivity: 97-100%
- Nearly all patients with secondary syphilis have reactive RPR
- This is the stage with highest test sensitivity
Early Latent Syphilis
- Sensitivity: 82-100% based on available studies 1
Specificity
- Approximately 99.5-99.7% in screening populations 3
- False positives can occur with autoimmune diseases, pregnancy, infections, and other conditions
Clinical Applications
Screening: The RPR serves as an initial screening test, particularly useful in high-volume settings like prenatal clinics where results can be obtained in 60-90 minutes 3. In pregnancy screening of 9,347 women, RPR showed 90.9% sensitivity and 99.6% specificity 3.
Treatment Monitoring: Quantitative titers should decline after successful treatment. However, this process is slow and variable 4:
- Only 42% of treated patients achieved seroreversion (non-reactive result) at median 235 days post-treatment
- HIV-positive patients, those with late latent syphilis, and those with subsequent reinfections are less likely to serorevert
- A 4-fold decline in titer (e.g., from 1:64 to 1:16) typically indicates treatment response
Reinfection Detection: A 4-fold or greater rise in titer suggests reinfection or treatment failure.
Important Caveats and Pitfalls
⚠️ The RPR is NOT specific for syphilis—it detects antibodies to cellular damage, not the organism itself. All reactive RPR tests must be confirmed with treponemal-specific tests (TPPA, FTA-ABS, or treponemal EIA).
⚠️ Serofast state: Some patients maintain low-level reactive titers (typically ≤1:4) indefinitely after treatment despite cure. This occurs in approximately 15-25% of treated patients and makes distinguishing reinfection from prior treated infection challenging 4.
⚠️ HIV coinfection affects test performance and serologic response. HIV-positive patients may have higher initial titers, slower serologic decline, and are less likely to achieve seroreversion 4.
⚠️ Prozone phenomenon: Very high antibody concentrations in secondary syphilis can paradoxically cause false-negative results if serum is not diluted. Laboratories typically screen at multiple dilutions to avoid this.
⚠️ Finger-stick/point-of-care RPR versions show significantly lower sensitivity (69.7%) compared to standard serum RPR and are not reliable alternatives 5.
⚠️ Automated RPR platforms show lower sensitivity (52.5%) than conventional RPR card tests (86.4%) but may be useful for monitoring treatment response due to higher seroconversion rates 6.
Interpretation Algorithm
For a reactive RPR result:
- Confirm with treponemal test (TPPA, FTA-ABS, or treponemal EIA)
- If treponemal test positive: Likely true syphilis (current or past)
- Check clinical history and prior treatment records
- High titers (≥1:16) suggest active infection requiring treatment
- Low titers (≤1:4) may represent treated infection or early disease
- If treponemal test negative: Likely false-positive RPR
- Consider causes: pregnancy, autoimmune disease, recent vaccination, other infections
For infants born to mothers with syphilis, approximately 75% will have RPR seroreversion by 3 months of age, and 96% by 6 months 7. Persistent reactivity beyond 6 months is uncommon and associated with higher birth titers.